NCT02174679No Longer Available不适用
68Ga-DOTATATE Imaging in Neuroendocrine Tumors
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
To evaluate 68Ga-DOTATATE PET/CT for staging of patients with carcinoid, neuroendocrine tumors, medullary thyroid cancer and other cancers expressing somatostatin receptors.
详细描述
This is an expanded access study with a total of 300 participants with NET and suspected SSTR positive tumors. Eligible participants will undergo baseline assessments at enrollment. Study participants will receive 68Ga-DOTATATE and will undergo a PET/CT imaging study. All patients referred by Oncologists will be screened by a UCLA Nuclear Medicine physician and then accepted for scanning if clinically appropriate.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Older than 18 years the time of radiotracer administration
- •Provides written informed consent
- •Known diagnosis of NET or suspected SSTR positive tumors Women of childbearing age must have a negative pregnancy test at screening/baseline
- •Able to remain still for duration of each imaging procedure (about 30 minutes)
排除标准
- •Less than 18 years-old at the time of radiotracer administration
- •Pregnant or nursing
- •Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
- •Any additional medical condition, serious concurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance.
研究者
研究点 (1)
Loading locations...
相似试验
No Longer Available
不适用
68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access TrialNeuroendocrine TumorsNCT02358018Memorial Sloan Kettering Cancer Center
Unknown
1 期
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine TumorsNeuroendocrineNeuroendocrine CancerNeuroendocrine CarcinomaCarcinoid TumorIslet Cell TumorApudomaNeuroendocrine TumorCarcinoidNCT02038738Ochsner Health System250
已完成
2 期
68Ga-DOTATATE PET Scan in Neuroendocrine CancerNeuroendocrine CarcinomaNCT01396382Vanderbilt-Ingram Cancer Center97
终止
早期 1 期
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsMetastatic Well Differentiated Neuroendocrine NeoplasmSomatostatin Positive Neoplastic Cells PresentNeuroendocrine NeoplasmVon Hippel-Lindau SyndromeMeningiomaMultiple Endocrine Neoplasia Type 1NCT03001349M.D. Anderson Cancer Center4
已完成
2 期
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine TumorsNeuroendocrine TumorsCarcinoid TumorsMedulloblastomaNeuroblastomaNCT02441062Sue O'Dorisio122